Stock Rating Downgrade
In recent days the Value Trend Rating for Sanofi (NASDAQ: SNY) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
On 5/24/24, Sanofi (NASDAQ: SNY) stock declined slightly by -0.9%, closing at $48.54. However, this decline was accompanied by unusually low trading volume at 66% of normal. Relative to the market the stock has been weak over the last nine months and has declined -0.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, SNY is expected to continue to be a major Value Builder.
Sanofi has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Sanofi has a slightly positive Appreciation Score of 62 but a poor Power Rating of 23, leading to the Negative Value Trend Rating.
Be the first to comment